ADAPTIVENCT07037901
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 15 versions: 14 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 15 words
- Trial sites expanded: 30 → 33 locations
- Minor Trial sites expanded: 23 → 30 locationsv14
Notable Primary completion pushed from Nov 2026 to Dec 2027v13 Show 7 more changesShow less
- Primary endpoint(s) modified
- Enrollment increased: 220 → 405 participants
- Study completion pushed from Oct 2027 to Aug 2028
- Trial arms changed: 4 → 9
- Secondary endpoints revised (4)
- Study description revised
- Study sites revised (23)
- Minor Study sites: 21 to 23v12
- Minor Study sites: 20 to 21v11
Show 8 earlier versionsHide 8 earlier versions
- Minor Study sites: 19 to 20v10
- Minor Study sites: 18 to 19v9
- Minor Study sites: 9 to 18v8
- Minor Study sites: 8 to 9v6
- Minor Study sites: 7 to 8v5
- Minor Study sites: 4 to 7v4
- Minor Study sites: 3 to 4v3
- Notable Trial status: Not Yet Recruiting to Recruiting
- Study sites: 0 to 3
- Start date changed from estimate of Jun 2025 to Jun 17, 2025
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (4)
Arms and interventions
Subcutaneous injection as per protocol.
Subcutaneous injection as per protocol.
Subcutaneous injection as per protocol.
Subcutaneous injection as per protocol.
Subcutaneous injection as per protocol.
Subcutaneous injection as per protocol.
Subcutaneous injection as per protocol.
Subcutaneous placebo injection as per protocol. At crossover, IMG-007 subcutaneous injection as per protocol.
Subcutaneous placebo injection as per protocol. At crossover, IMG-007 subcutaneous injection as per protocol.
Drugs: IMG-007, Placebo
Sites
33 sites in 4 countries
United States 16, Australia 8, Canada 7, New Zealand 2